Home Magazine Past Issues Feature

When A Small Bio Company Receives Big Funding

Written by
Armed with $47 million, Virdante Pharmaceuticals is now methodically seeking partners for its development of two anti-inflammatory drugs. Virdante Pharmaceuticals of Cambridge, MA has officially…

Monoclonal Antibodies: The Next Generation

Written by
The commercial success of therapeutic monoclonal antibodies (MAbs) to treat cancer, immune dysfunction, and infectious diseases has catapulted these once difficult-to-develop molecules to the forefront…

In His Own Words: Fred Hassan

The following is an edited excerpt of an interview conducted by MeetTheBoss TV, featuring former Schering-Plough CEO Fred Hassan. Go to MeetTheBoss.tv to watch the…

Building A Generics Giant

Written by
To say Heather Bresch has seen a lot of change happen at Mylan would be an understatement. She’s been with the company for 19 years,…